NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017 [Canadian Business Journal (Canada)]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Canadian Business Journal
NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017 FT. MYERS, FL –(Marketwired – July 25, 2017) – NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of cancer-focused genetic testing services, today reported its results for the second quarter of 2017. Second Quarter 2017 Highlights: 16% increase in clinical genetic testing volume (1) 5% increase in consolidated revenue to $66.1 million 13% reduction in average cost per clinical genetic test (1) Significant improvement in Gross Margin to 47.2% from 45.3% in Q2 16 GAAP EPS of ($0.03) per share and non-GAAP Adj. Diluted EPS (2) of $0.04 per share Consolidated revenues for the second quarter were $66.1 million, an increase of 5% over the same period last year. Clinical genetic test volume (1) increased 16% year over year, and average revenue per clinical genetic test (“Revenue per Test”) decreased by
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics announces senior leadership promotions [Seeking Alpha]Seeking Alpha
- NeoGenomics Announces Senior Leadership Promotions [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Announces Senior Leadership PromotionsBusiness Wire
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024Business Wire
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
NEO
Earnings
- 2/20/24 - Beat
NEO
Sec Filings
- 4/18/24 - Form 8-K
- 4/8/24 - Form ARS
- 4/8/24 - Form DEFA14A
- NEO's page on the SEC website